Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.
2.

Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado.

Mullineaux LG, Castellano TM, Shaw J, Axell L, Wood ME, Diab S, Klein C, Sitarik M, Deffenbaugh AM, Graw SL.

Cancer. 2003 Aug 1;98(3):597-602. Review.

3.

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.

Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, Rahaman JA, Robson ME, Offit K, Barakat RR, Soslow RA, Boyd J.

J Clin Oncol. 2003 Nov 15;21(22):4222-7. Review.

PMID:
14615451
4.

Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.

Wang F, Fang Q, Ge Z, Yu N, Xu S, Fan X.

Mol Biol Rep. 2012 Mar;39(3):2109-18. doi: 10.1007/s11033-011-0958-0. Epub 2011 Jun 4. Review.

PMID:
21643751
5.

Breast cancer genetics in African Americans.

Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C.

Cancer. 2003 Jan 1;97(1 Suppl):236-45. Review.

6.

Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.

Heisey RE, Carroll JC, Warner E, McCready DR, Goel V.

Can Fam Physician. 1999 Jan;45:114-24. Review.

7.

Ethnic differences in cancer risk resulting from genetic variation.

Neuhausen SL.

Cancer. 1999 Dec 1;86(11 Suppl):2575-82. Review.

PMID:
10630184
8.

BRCA1 and prostate cancer.

Rosen EM, Fan S, Goldberg ID.

Cancer Invest. 2001;19(4):396-412. Review.

PMID:
11405179
9.

Hereditary breast cancer in Jews.

Rubinstein WS.

Fam Cancer. 2004;3(3-4):249-57. Review.

PMID:
15516849
10.

Germ line mutations associated with breast cancer susceptibility.

Iau PT, Macmillan RD, Blamey RW.

Eur J Cancer. 2001 Feb;37(3):300-21. Review.

PMID:
11239752
11.

BRCA1 and BRCA2 gene mutations and risk of breast cancer. Public health perspectives.

Coughlin SS, Khoury MJ, Steinberg KK.

Am J Prev Med. 1999 Feb;16(2):91-8. Review.

PMID:
10343884
12.

BRCA2 and pancreatic cancer.

Naderi A, Couch FJ.

Int J Gastrointest Cancer. 2002;31(1-3):99-106. Review.

PMID:
12622420
13.

A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.

Karami F, Mehdipour P.

Biomed Res Int. 2013;2013:928562. doi: 10.1155/2013/928562. Epub 2013 Nov 7. Review.

14.

The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.

Sundararajan S, Ahmed A, Goodman OB Jr.

Clin Adv Hematol Oncol. 2011 Oct;9(10):748-55. Review.

PMID:
22252577
15.

Clinical features and management of BRCA1 and BRCA2-associated prostate cancer.

Alanee SR, Glogowski EA, Schrader KA, Eastham JA, Offit K.

Front Biosci (Elite Ed). 2014 Jan 1;6:15-30. Review.

PMID:
24389137
16.

Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.

Ossa CA, Torres D.

Oncologist. 2016 Jul;21(7):832-9. doi: 10.1634/theoncologist.2015-0416. Epub 2016 Jun 10. Review.

17.

Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation Carriers.

Gleicher S, Kauffman EC, Kotula L, Bratslavsky G, Vourganti S.

Prostate. 2016 Sep;76(13):1135-45. doi: 10.1002/pros.23204. Epub 2016 May 26. Review.

18.

Founder mutations in BRCA1 and BRCA2 genes.

Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G, Carreca I, Surmacz E, Colucci G, Bazan V, Russo A.

Ann Oncol. 2007 Jun;18 Suppl 6:vi93-8. Review.

PMID:
17591843
19.

The role of BRCA1 and BRCA2 in prostate cancer.

Castro E, Eeles R.

Asian J Androl. 2012 May;14(3):409-14. doi: 10.1038/aja.2011.150. Epub 2012 Apr 23. Review.

20.

Family studies and the evidence for genetic susceptibility to prostate cancer.

Bishop DT, Kiemeney LA.

Semin Cancer Biol. 1997 Feb;8(1):45-51. Review.

PMID:
9299581

Supplemental Content

Support Center